Navigation Links
International Isotopes Inc. Announces the Completion of an Agreement in Principle With Idaho State University for the Production of Copper-67 for Experimental Use in Cancer Treatment
Date:11/8/2011

IDAHO FALLS, Idaho, Nov. 8, 2011 /PRNewswire/ -- International Isotopes Inc. (OTC Bulletin Board: INIS), a leading manufacturer of nuclear medicine products, is pleased to announce it has completed an agreement in principle with Idaho State University to jointly develop processes for the production of Copper-67.  Copper-67 has shown exceptional potential in the treatment of non-Hodgkin's Lymphoma as well as bladder, colorectal, and ovarian cancers.  However, it is a difficult isotope to produce and has not been consistently made available in the U.S.  This has restricted its evaluation in cancer research and clinical trials.

Idaho State University (ISU) has developed what is believed to be a technologically advanced method for producing the isotope using technologies housed in the Idaho Accelerator Center.  Under the terms of the anticipated definitive agreement, ISU will produce the raw isotope at their accelerator center and International Isotopes will transfer the material to its facility where it will be processed and packaged in its final form.   In addition to its work at the accelerator center, ISU is providing the expertise for chemical processing.  International Isotopes will make an in- kind contribution of equipment for the isotope processing, technical support for packaging and shipping, and supporting safety staff. The International Isotopes' facility is specifically licensed by the Nuclear Regulatory Commission for this type of activity and its facility is also registered with the U.S. Food and Drug Administration as a manufacturing facility for drug products – a classification that will help facilitate the commercial development of the Copper-67 product.  The parties expect to have definitive agreements executed within the coming weeks and plan to begin work later this month.    

Steve T. Laflin, President and CEO of INIS stated, "We are very pleased to have the opportunity to work so closely with Idaho State University on the development of this important isotope.  Copper-67 has shown great promise in the treatment of several cancers and making this isotope readily and reliably available in the U.S. should help provide an additional important weapon in our nation's fight against cancer.  In addition to the positive health aspects of this isotope, I think it is especially noteworthy that we have been able to join the resources of an Idaho business and an Idaho university to proactively collaborate on the production of this potentially important medical isotope."

Dr. Arthur C. Vailas, President of ISU stated, "The agreement in principle with International Isotopes is another example of how ISU is leading the way in developing translational, cutting-edge research in the areas of health and nuclear research.  The partnership with International Isotopes will provide exciting new, potentially beneficial treatment for those afflicted with various types of cancers.  To be able to play a role in treating these diseases is exciting and speaks to the University's role as a distinguished research university leading in opportunity and innovation through research, education and service."

About Idaho State University

Idaho State University is the state's designated lead institution in health professions and medical education.

About International Isotopes Inc.

International Isotopes Inc. manufactures a full range of nuclear medicine calibration and reference standards, high purity fluoride gases, and a variety of cobalt-60 products such as teletherapy sources.  The Company also provides a wide selection of radioisotopes and radiochemicals for medical devices, calibration, clinical research, life sciences, and industrial applications and provides a host of analytical, measurement, recycling, and processing services on a contract basis to clients. The Company is in the licensing and design phase of its planned environmentally friendly, green technology, uranium de-conversion and fluorine extraction processing facility located near Hobbs, New Mexico.

International Isotopes Inc. Safe Harbor Statement

Certain statements in this press release are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, including statements with respect to the future promise of copper-67 in the treatment of cancer, changes to the national availability of the isotope, and the ultimate accomplishments of the collaboration with ISU.  Information contained in such forward-looking statements is based on current expectations and is subject to change.  These statements involve a number of risks, uncertainties, and other factors that could cause actual results, performance or achievements of International Isotopes, Inc. to be materially different from any future results, performance or achievements expressed or implied by these forward-looking statements.  Other factors, which could materially affect such forward-looking statements, can be found in International Isotopes, Inc.'s filings with the Securities and Exchange Commission at www.sec.gov, including our annual report on Form 10-K for the year ending December 31, 2010.  Investors, potential investors and other readers are urged to consider these factors carefully in evaluating the forward-looking statements and are cautioned not to place undue reliance on such forward-looking statements.  The forward-looking statements made herein are only made as of the date of this press release and International Isotopes, Inc. undertakes no obligation to publicly update such forward-looking statements to reflect subsequent events or circumstances.

FOR MORE INFORMATION CONTACT:

Jim Drewitz
Creative Options Communications
Investor and Public Relations
jim@jdcreativeoptions.com
Phone:  830-669-2466
www.jdcreativeoptions.com

For more information, please visit the Company web site:  www.intisoid.com


'/>"/>
SOURCE International Isotopes Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. International Experts Outline Public Health Initiatives for Future Dengue Vaccine Introduction and Control of Dengue Fever
2. Psychemedics Awarded ISO/IEC 17025 International Accreditation
3. UC San Diego Clinical Trials for Latin America International Seminar at Hospital Angeles in Tijuana
4. PAREXEL International to Present at Lazard Capital Markets Healthcare Conference and Citi Small/Mid Cap Conference
5. Dyadic International Reports 2011 Third Quarter Financial Results
6. Mettler-Toledo International Inc. Reports Third Quarter 2011 Results
7. Ellman International Introduces the New Ellumine Laser at the American Society for Dermatologic Surgery (ASDS) 2011 Annual Meeting
8. Telik Announces Ezatiostat (Telintra®) Preclinical Presentation at the 2011 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
9. HeartWare International Announces Planned Departure of Chief Financial Officer
10. HeartWare International Reports Third Quarter 2011 Revenues of $21.3 Million; 54% Increase From $13.8 Million in Third Quarter 2010
11. Mettler-Toledo International Inc. to Host Third-Quarter 2011 Earnings Conference Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/10/2017)... -- NDS received FDA 510(k) clearance in May 2017 for its highly ... designed for endoscopy environments. An innovative secondary monitor solution, ZeroWire ... support the improvement of patient outcomes, procedural efficiency, and the lowering ... ... ...
(Date:10/4/2017)... 4, 2017  South Korean-based healthcare product Development Company ... "cprCUBE" on Kickstarter. The device will educate the user ... with better efficiency compared to the dated and pricey ... on efficacy of the compression for a more informed ... goal to raise $5,000. ...
(Date:10/2/2017)... 2017  Eli Lilly and Company (NYSE: ... third quarter of 2017 on Tuesday, October 24, 2017. ... day with the investment community and media to further ... call will begin at 9 a.m. Eastern time. Investors, ... webcast of the conference call through a link that ...
Breaking Medicine Technology:
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... Apple ... care services, staged a mock evacuation of the facility as part of a disaster ... Fire Department, Echo Hose EMS and Shelton City Emergency Manager, as well as the ...
(Date:10/13/2017)... , ... October 13, 2017 , ... Global Healthcare Management’s ... Alexandria Park in Milford, NJ. This free event, sponsored by Global Healthcare Management’s ... The fun run is geared towards children of all ages; it is a ...
(Date:10/13/2017)... ... October 13, 2017 , ... “The Journey: From the ... danger possible to save lost souls in the Philippines. “The Journey: From the Mountains ... a dedicated teacher of the Bible. She has taught all ages and currently teaches ...
(Date:10/12/2017)... ... October 12, 2017 , ... Planet Fitness, one of the largest and ... plans to open a flagship location in Covington, LA at 401 N. U.S. Highway ... store next to Office Depot in the Holiday Square shopping center. Its location allows ...
(Date:10/12/2017)... ... 2017 , ... Asante, a nationally recognized health system in ... existing home health joint venture through an agreement, effective October 1, 2017, to ... home health company with Asante, delivering clinically integrated care, for the past eight ...
Breaking Medicine News(10 mins):